For research use only
| Cat No. | ABC-TC148W |
| Product Type | Blood Products |
| Cell Type | Serum |
| Species | Human |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Blood |
| Disease | Ovarian Cancer |
| Storage | Liquid Nitrogen |
Human Ovarian Cancer Serum is used to study biomarkers, cancer progression, and therapeutic responses. Ideal for drug screening and cancer research.
Human Ovarian Cancer Serum is a biological sample derived from ovarian cancer patients, utilized to study cancer biomarkers, tumor progression, and therapeutic responses. This serum contains a wide range of proteins, cytokines, and growth factors that are involved in tumor biology and metastasis. It is commonly used in research to investigate cancer signaling pathways, cell migration, and angiogenesis. Furthermore, Human Ovarian Cancer Serum plays a crucial role in drug screening assays, helping to identify new therapeutic agents and assess their efficacy in vitro. This serum is also essential for understanding the molecular mechanisms underlying ovarian cancer progression and for developing targeted therapies for better clinical outcomes.
| Species | Human |
| Cat.No | ABC-TC148W |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Serum |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Blood |
| Disease | Ovarian Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Ovarian Cancer Serum is used in biomarker discovery and drug screening assays to identify potential therapeutic agents for ovarian cancer. It is essential for studying ovarian cancer progression, cell migration, and angiogenesis. Researchers use this serum to investigate the molecular pathways involved in tumor biology and metastasis. Additionally, it provides a model for evaluating the efficacy of targeted therapies in preclinical research, contributing to the development of personalized medicine for ovarian cancer patients.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).